{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:19Z","timestamp":1786979839611,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:00:00Z","timestamp":1555113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00240-019-01128-y","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T22:04:40Z","timestamp":1555106680000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria"],"prefix":"10.1007","volume":"47","author":[{"given":"Deepa A.","family":"Malieckal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Modersitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity T.","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Asplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"issue":"4","key":"1128_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MNH.0b013e3283621c5d","volume":"22","author":"N Sumorok","year":"2013","unstructured":"Sumorok N, Goldfarb DS (2013) Update on cystinuria. Curr Opin Nephrol Hypertens 22(4):427\u2013431","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"1128_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0022-5347(17)45188-3","volume":"136","author":"CY Pak","year":"1986","unstructured":"Pak CY, Fuller C, Sakhaee K, Zerwekh JE, Adams BV (1986) Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol 136(5):1003\u20131008","journal-title":"J Urol"},{"issue":"5","key":"1128_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0022-5347(05)67633-1","volume":"163","author":"F Barbey","year":"2000","unstructured":"Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163(5):1419\u20131423","journal-title":"J Urol"},{"issue":"2","key":"1128_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0022-5347(05)66044-2","volume":"166","author":"FL Coe","year":"2001","unstructured":"Coe FL, Clark C, Parks JH, Asplin JR (2001) Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol 166(2):688\u2013693","journal-title":"J Urol"},{"issue":"6","key":"1128_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/sj.ki.5000104","volume":"69","author":"DS Goldfarb","year":"2006","unstructured":"Goldfarb DS, Coe FL, Asplin JR (2006) Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int 69(6):1041\u20131047","journal-title":"Kidney Int"},{"issue":"3","key":"1128_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/end.2005.19.429","volume":"19","author":"DJ Dolin","year":"2005","unstructured":"Dolin DJ, Asplin JR, Flagel L, Grasso M, Goldfarb DS (2005) Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol 19(3):429\u2013432","journal-title":"J Endourol"},{"issue":"5","key":"1128_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0022-5347(05)67011-5","volume":"164","author":"Y Nakagawa","year":"2000","unstructured":"Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL (2000) Clinical use of cystine supersaturation measurements. J Urol 164(5):1481\u20131485","journal-title":"J Urol"},{"issue":"4","key":"1128_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1046\/j.1523-1755.1999.00682.x","volume":"56","author":"JR Asplin","year":"1999","unstructured":"Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL (1999) Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56(4):1505\u20131516","journal-title":"Kidney Int"},{"issue":"1\u20132","key":"1128_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0009-8981(99)00159-X","volume":"289","author":"Y Nakagawa","year":"1999","unstructured":"Nakagawa Y, Coe FL (1999) A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta 289(1\u20132):57\u201368","journal-title":"Clin Chim Acta"},{"issue":"23","key":"1128_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1056\/NEJM196512022732303","volume":"273","author":"LE Rosenberg","year":"1965","unstructured":"Rosenberg LE, Durant JL, Holland JM (1965) Intestinal absorption and renal extraction of cystine and cysteine in cystinuria. N Engl J Med 273(23):1239\u20131245","journal-title":"N Engl J Med"},{"issue":"5","key":"1128_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/00003088-198713050-00003","volume":"13","author":"P Netter","year":"1987","unstructured":"Netter P, Bannwarth B, Pere P, Nicolas A (1987) Clinical pharmacokinetics of D-penicillamine. Clin Pharmacokinet 13(5):317\u2013333","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1128_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF00315354","volume":"45","author":"MS Carlsson","year":"1993","unstructured":"Carlsson MS, Denneberg T, Emanuelsson BM, Kagedal B, Lindgren S (1993) Pharmacokinetics of oral tiopronin. Eur J Clin Pharmacol 45(1):79\u201384","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1128_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/BF00196122","volume":"46","author":"MS Carlsson","year":"1994","unstructured":"Carlsson MS, Denneberg T, Emanuelsson BM, Kagedal B, Lindgren S (1994) The pharmacokinetics of tiopronin as such is unknown. Eur J Clin Pharmacol 46(6):576\u2013577","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1128_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.juro.2017.09.034","volume":"199","author":"JI Friedlander","year":"2018","unstructured":"Friedlander JI, Antonelli JA, Canvasser NE, Morgan MSC, Mollengarden D, Best S, Pearle MS (2018) Do urinary cystine parameters predict clinical stone activity? J Urol 199(2):495\u2013499","journal-title":"J Urol"},{"issue":"1","key":"1128_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00240-008-0166-0","volume":"37","author":"JW Goodman","year":"2009","unstructured":"Goodman JW, Asplin JR, Goldfarb DS (2009) Effect of two sports drinks on urinary lithogenicity. Urol Res 37(1):41\u201346","journal-title":"Urol Res"},{"issue":"1","key":"1128_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0022-5347(05)66142-3","volume":"166","author":"DS Goldfarb","year":"2001","unstructured":"Goldfarb DS, Asplin JR (2001) Effect of grapefruit juice on urinary lithogenicity. J Urol 166(1):263\u2013267","journal-title":"J Urol"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-019-01128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00240-019-01128-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-019-01128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:31:50Z","timestamp":1586633510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00240-019-01128-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,13]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1007\/s00240-019-01128-y","relation":{},"ISSN":["2194-7228","2194-7236"],"issn-type":[{"value":"2194-7228","type":"print"},{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,13]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Malieckal: none; Modersitzki: none; Mara: none; Enders: none; Asplin: employee, Litholink Corp; Goldfarb: consultant, Retrophin; funding from NIDDK, NCATS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}